OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
4.660
-0.050 (-1.06%)
Aug 25, 2026, 4:00 PM EDT - Market closed
OmniAb Employees
OmniAb had 89 employees as of December 31, 2025. The number of employees decreased by 25 or -21.93% compared to the previous year.
Employees
89
Change (1Y)
-25
Growth (1Y)
-21.93%
Revenue / Employee
$432,101
Profits / Employee
-$497,416
Market Cap
677.52M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 89 | -25 | -21.93% |
| Dec 31, 2024 | 114 | 8 | 7.55% |
| Dec 31, 2023 | 106 | 11 | 11.58% |
| Dec 31, 2022 | 95 | 21 | 28.38% |
| Sep 30, 2022 | 93 | 23 | 32.86% |
| Jun 30, 2022 | 87 | 17 | 24.29% |
| Dec 31, 2021 | 74 | 4 | 5.71% |
| Sep 30, 2021 | 70 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Autolus Therapeutics | 754 |
| Arvinas | 246 |
| CorMedix | 191 |
| Verastem | 102 |
| Scribe Therapeutics | 89 |
| AgomAb Therapeutics NV | 62 |
| Altimmune | 57 |
OABI News
- 8 days ago - OmniAb raises FY26 cash and equivalents view to $49M-$53M vs. $37M-$41M - TheFly
- 8 days ago - OmniAb Raises 2026 Financial Guidance - Business Wire
- 8 days ago - OmniAb announces collaboration and license agreement with Eli Lilly - TheFly
- 8 days ago - OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company - Business Wire
- 15 days ago - OmniAb Slides: Corporate presentation - Filings
- 19 days ago - OmniAb reports Q2 EPS (5c), consensus (13c) - TheFly
- 19 days ago - OmniAb raises FY26 revenue view to $32M-$36M from $28M-$33M - TheFly
- 19 days ago - OmniAb Earnings Call Transcript: Q2 2026 - Transcripts